Roche - Inflammation
Links shared publicly online about this topic.
- 1,978total visits
Roche - Inflammation
View full resource at roche.com
Tags: Immune, Autoimmune Disease, Arthritis, Rheumatoid Arthritis, Disease and Condition
Most Recently Shared on June 11, 2009 at 9:29 am By:
Watch video describing rheumatoid arthritis here: http://www.roche.com/inflammation.htm
Roche chases stake in medical sequencing : Nature News & Comment
nature.com — “Biotech firm Illumina continues to resist takeover — but analysts suggest that a merger is inevitable.” View full resource at nature.com
Most Recently Shared on April 11, 2012 at 3:29 am By:
Anas Younes, M.D. Physician, Doctor, Internist, and Oncologist
Roche chases stake in medical sequencing http://t.co/0oxqghCi
Roche sponsors Twitter-based diabetes community | InPharm
inpharm.com — “InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.” View full resource at inpharm.com
Most Recently Shared on April 5, 2012 at 10:59 am By:
Pharmafocus Pharma and Health News
Roche sponsors Twitter-based diabetes community - http://t.co/2bqpwWtl
Disclaimer
transactioninfo.com — “Disclaimer” View full resource at transactioninfo.com
Most Recently Shared on April 3, 2012 at 1:42 pm By:
FYI, Roche's press release on Illumina's latest rejection: http://t.co/tazmVH6k $ROG #pharma
Illumina Rejects Roche's Boosted Offer - WSJ.com
online.wsj.com — “Illumina's board unanimously rejected Swiss drug maker Roche's sweetened takeover offer, saying the revised bid is still inadequate and opportunistic.” View full resource at online.wsj.com
Most Recently Shared on April 3, 2012 at 12:42 am By:
Illumina Rejects Roche's Boosted Offer http://t.co/vLLevbHZ
preview
emailactivity.ecn5.com — “preview” View full resource at emailactivity.ecn5.com
Most Recently Shared on March 30, 2012 at 7:01 pm By:
PharmaLive Pharma and Health News
#Genentech, #Roche to File BLA for Breast Cancer Drug http://t.co/2WhioI1U #DailyAdvantage
PharmaLive: Ignite Health Teams Up with Roche to Re-Envision “Diabetes Nest,” a Twitter-Based Social Network
pharmalive.com — “PharmaLive: Ignite Health Teams Up with Roche to Re-Envision “Diabetes Nest,” a Twitter-Based Social Network” View full resource at pharmalive.com
Most Recently Shared on March 30, 2012 at 5:00 pm By:
PharmaLive Pharma and Health News
Ignite Health Teams Up with Roche to Re-Envision “Diabetes Nest,” a Twitter-Based Social Network http://t.co/vUFXY1Sh
Trial of bevacizumab add-on therapy in advanced prostate cancer negative - The Doctor's Channel
thedoctorschannel.com — “NEW YORK (Reuters Health) – The addition of bevacizumab (Avastin; Genentech/Roche) to the standard docetaxel and prednisone in men with progressive metastatic castration-resistant prostate cancer (mCRPC) did not improve overall survival and was associated with greater toxicity...” View full resource at thedoctorschannel.com
Most Recently Shared on March 29, 2012 at 10:37 pm By:
Dr Michael Banks - The Doctor's Channel Health Site
Are there any benefits to taking bevacizumab in cases of advanced prostate cancer? - From Reuters Health/TDC http://t.co/ZrZ76DEN #oncology
Roche Raises Illumina Takeover Bid to $51/Share | Xconomy
xconomy.com — “Roche has raised the stakes in its ongoing hostile takeover bid for San Diego-based Illumina (NASDAQ: ]) The Switzerland-based healthcare giant said it has” View full resource at xconomy.com
Most Recently Shared on March 29, 2012 at 3:16 pm By:
Christiane Truelove Health Communicator
RT @ldtimmerman: Roche raises Illumina takeover bid to $51/share. Stock rises even more http://t.co/64XzNnKV
Roche Cuts the Price of Cancer Drugs in India – Under Pressure? | BioPortfolio.com
bioportfolio.com — “From BioPortfolio: Last week, Roche said it would “significantly” reduce the price the company charges in India for two expensive biotech cancer drugs &nda...” View full resource at bioportfolio.com
Most Recently Shared on March 29, 2012 at 11:03 am By:
BioPortfolio News Roche Cuts the Price of Cancer Drugs in India Under Pressure: Last week Roc... http://t.co/F25SeprI BioPortfolio News
Case study: role for the finance team - FT.com
ft.com — “The story. Roche Group, the Swiss global healthcare company, had owned a majority stake in Genentech since 1990. The California-based biotechnology company had become an increasingly important part of Roche’s business and, in order to strengthenco-op” View full resource at ft.com
Most Recently Shared on March 26, 2012 at 11:20 pm By:
blogaceutics Pharma and Health Communicator
Case study: role for the #finance team [at Roche] - http://t.co/6q83KLw8 http://t.co/1Ru3GpbY
Columbia University sues Illumina over DNA patents - Yahoo! News
news.yahoo.com — “From Yahoo! News: (Reuters) - Illumina Inc, a gene-mapping company facing a $5.7 billion hostile takeover bid by Swiss drugmaker Roche Holding AG, was sued by Columbia University on Monday for allegedly infringing five patents related to DNA sequencing. According to the complaint filed in the U.S. District Court in Wilmington, Delaware, Illumina commercialized its so-called next-generation sequencing (NGS) products despite knowing about the patents, obtained between 2009 and 2012 and assigned to” View full resource at news.yahoo.com
Most Recently Shared on March 26, 2012 at 7:06 pm By:
HealthTrendster Health Executive
Columbia University sues Illumina over DNA patents - (Reuters) - Illumina Inc, a gene-mapping company facing a $5.7 ... http://t.co/H6SIHuYI
Sanofi loses appeal over Roche/Biogen patent infringement - NEWS - General articles - Pharmaceutical Industry - PMLiVE
pmlive.com — “Pharmaceutical Industry | NEWS | General | Sanofi loses appeal over Roche/Biogen patent infringement - Court upholds decision that Genentech did not use Sanofi inventions during development of Rituxan and Avastin | PMLiVE” View full resource at pmlive.com
Most Recently Shared on March 26, 2012 at 5:16 pm By:
blogaceutics Pharma and Health Communicator
Sanofi loses appeal over Roche/Biogen patent infringement - PMLiVE http://t.co/PUdOrd7K
Columbia University sues Illumina over DNA patents - Yahoo! News
news.yahoo.com — “From Yahoo! News: (Reuters) - Illumina Inc, a gene-mapping company facing a $5.7 billion hostile takeover bid by Swiss drugmaker Roche Holding AG, was sued by Columbia University on Monday for allegedly infringing five patents related to DNA sequencing. According to the complaint filed in the U.S. District Court in Wilmington, Delaware, Illumina commercialized its so-called next-generation sequencing (NGS) products despite knowing about the patents, obtained between 2009 and 2012 and assigned to” View full resource at news.yahoo.com
Most Recently Shared on March 26, 2012 at 3:51 pm By:
HealthTrendster Health Executive
Illumina sued by Columbia University over DNA patents - (Reuters) - Illumina Inc, facing a hostile takeover bid by S... http://t.co/ms5532lX
Roche to Cut Prices in India on Two Cancer Drugs - WSJ.com
online.wsj.com — “Roche is cutting the price of two expensive cancer drugs in India in an effort to gain market share and avoid competition from generic drugs in the fast-growing economy.” View full resource at online.wsj.com
Most Recently Shared on March 26, 2012 at 12:39 pm By:
Cary Byrd - eDrugSearch.com Pharma and Health Advocate
Roche to Cut Prices in India on Two Cancer Drugs - http://t.co/NgjsbFLE http://t.co/yN6QlFXD
Illumina Comments on Second Extension of Roche's Unsolicited Tender Offer - Drugs.com MedNews
drugs.com — “Mar 26, 2012 - Illumina, Inc. (NASDAQ ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of ge” View full resource at drugs.com
Most Recently Shared on March 26, 2012 at 12:06 pm By:
Drugs and Devices OW OW Health
Illumina Comments on Second Extension of Roche's Unsolicited Tender Offer: SAN DIEGO--(BUSINESS WIRE)--Mar... http://t.co/4tmwxCCi #drug
Advertisement
